MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer's Disease

Ivana Raffaele1, Serena Silvestro1, Emanuela Mazzon1

  • 1IRCCS Centro Neurolesi Bonino Pulejo, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.

Insights

MicroRNAs (miRNAs) are implicated in Alzheimer's disease (AD) by affecting mitogen-activated protein kinases (MAPK) signaling. Targeting specific miRNAs, like miR-132, shows potential for treating AD by reducing pathology and improving cognition.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Alzheimer's disease (AD) is the primary cause of dementia globally, characterized by neurodegeneration.
  • Dysregulated microRNAs (miRNAs) are observed in AD patients, suggesting their involvement in disease progression.
  • Mitogen-activated protein kinases (MAPK) signaling pathways are crucial in cellular functions and can be disrupted in AD.

Purpose of the Study:

  • To review the molecular interplay between miRNAs and MAPKs in Alzheimer's disease pathogenesis.
  • To consolidate evidence from experimental AD models regarding miRNA-MAPK interactions.
  • To identify specific miRNAs with therapeutic potential in AD.

Main Methods:

  • Systematic literature review of publications from 2010-2023.
  • Searches conducted on PubMed and Web of Science databases.
  • Focus on experimental models of Alzheimer's disease.

Main Results:

  • Multiple miRNA deregulations were found to modulate MAPK signaling in various stages of AD.
  • Modulation of MAPK-regulating miRNAs (overexpression or silencing) ameliorated cognitive deficits in AD animal models.
  • miR-132 demonstrated neuroprotective effects by inhibiting amyloid-beta and Tau pathology and oxidative stress via ERK/MAPK1 signaling.

Conclusions:

  • miRNAs play a significant role in regulating MAPK signaling during AD pathogenesis.
  • miRNA-based interventions show promise for improving cognitive function in AD models.
  • Further research is needed to validate and translate these findings into clinical applications for Alzheimer's disease.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
575
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.2K